Pharmacogenetic considerations for late life depression therapy

Author： Pitychoutis Pothitos M Kokras Nikolaos Sanoudou Despina Dalla Christina Papadopoulou-Daifoti Zeta

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.8, 2013-08, pp. : 989-999

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetic considerations for non-Hodgkin's lymphoma therapy

By Espirito Santo Ana Medeiros Rui

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 12, 2013-12 ,pp. : 1625-1634

Informa Healthcare

Access to resources Recommend Favorite

Use of Antidepressants in Late-Life Depression

By Rajji Tarek K. Mulsant Benoit H. Lotrich Francis E.

Drugs & Aging, Vol. 25, Iss. 10, 2008-01 ,pp. : 841-853

Adis International

Access to resources Recommend Favorite

Pharmacogenetic Considerations in the Elderly Patient

By Bright David R. Calinski Diane M. Kisor David F.

The Consultant Pharmacist, Vol. 30, Iss. 4, 2015-04 ,pp. : 228-239

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Pharmacogenetics and the serotonin transporter in late-life depression

By Gerretsen Philip Pollock Bruce G

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 12, 2008-12 ,pp. : 1465-1478

Informa Healthcare

Access to resources Recommend Favorite

Late Life Depression: A Diagnostic and Pharmacological Review

Current Psychopharmacology, Vol. 3, Iss. 1, 2014-04 ,pp. : 32-41

Bentham Science Publishers

Access to resources Recommend Favorite